Continuing the theme of this blog, doctors and healthcare professionals have a unique edge in biotech investing, but you need to integrate that insight into a robust investing framework. This newsletter serves to help you with that integration. So, if you haven’t read my prior article on this topic, I encourage you to check it...
Yesterday, I shared Why Physicians and Healthcare Providers Make Great Biotech Investors. The takeaway? As a physician, your deep medical and scientific training puts you on the front lines of clinical care, giving you a unique edge in spotting breakthrough developments before they hit the radar. Here’s a perfect example that proves it. I recently...
As physicians and healthcare providers, you’ve spent years in medical school and clinical practice mastering medicine, biostatistics, and more. But let’s be real—investing and finance? Those weren’t part of the curriculum. So, you might think biotech investing is out of your league, something reserved for Wall Street wizards. That’s conventional wisdom. And it’s dead wrong....
The Berkshire Hathaway 2025 Annual Meeting held on May 3, 2025 marked the end of an era—and the beginning of a new chapter. Warren Buffett confirmed he will step down as CEO by the end of 2025, handing over the reins to Greg Abel, a proven leader with Buffett’s full confidence. Though stepping aside, Buffett...
At Evergrowth BioHealthcare Capital, we believe the key to successful investing lies in understanding a stock’s intrinsic value—the true worth of a company based on its fundamentals, not fleeting market sentiment. For young growth biotech stocks, intrinsic value is dynamic, evolving with each milestone in their journey from lab to market. Let’s explore how this...
Coronary Artery Disease or CAD is one of the leading health challenges worldwide. This condition is estimated to impact billions globally and remains a significant burden on healthcare systems. At Evergrowth, we see this condition as something that will prevail in the upcoming years especially with the current trend in lifestyle. Poor diet, lack of...
Did you know that there are sneaky, slow-growing neuroendocrine tumors that can disrupt lives with hormone overproduction and mysterious symptoms? These are called Carcinoid tumors which affect the gut, lungs, and sometimes even the heart. These tumors might be rare, but their impact? Enormous! While the causes of these tumors are uncertain, carcinoid tumor research...
Did you know that around 30,000 people worldwide are diagnosed with mesothelioma each year? This rare but deadly cancer, mostly caused by asbestos exposure, has been a silent threat lurking in our walls, our ceilings, and even our communities. And while famous people like Steve McQueen tragically battled this disease in the past, today we’re...
Imagine a disease that not only impacts 10 million people yearly but also challenges the world with drug-resistant strains. That disease is tuberculosis (TB), and it’s a silent crisis affecting lives across all backgrounds—even stars like Nelson Mandela, who battled TB during his time in prison. Fortunately, we are now seeing biotech innovations that are...
Pulmonary hypertension – a condition that not only affects millions worldwide but also claimed the life of legendary singer Natalie Cole. Today, we explore the battle against this life-altering disease. In 2024, pulmonary hypertension is estimated to affect 1% of the global population. The condition, often marked by shortness of breath, fatigue, and chest pain,...